Google ’ s Acquisition of FitBit: Boon or Doom for the fitness tracking industry?

There were rumours and you’ve heard the news: Google acquired Fitbit for a whopping $2.1 billion. With millions of user’s data now in the hands of Google, will the tech giant’s latest leap in the fitness industry put said industry in hyperdrive mode or will it allow Google to monopolize a significant chunk of the market with a Big Brother-esque control and access over users’ data? Well there are a lot of layers before coming to a conclusion and eventually only time will tell, so join us as we analyse the possible implications of one of the fitness industry’s biggest news! Source: Fitting In When Fitbit released its first device a decade ago, little did the company know that it would grow to become synonymous with fitness trackers. With over 27 million active users and nearly  90 million devices sold worldwide as of 2019, Fitbit’s is a success story which many of its past competitors are probably envious about; Jawbone and Lark are now distant memories but were fierce competitors back in the days, even Microsoft did not bother to venture forth in the wearable fitness market after its Microsoft Band 2. This left the market to Big Tech companies like Apple, Xiaomi, Huawei and a handful of smaller companies like Fitbit and, our darling here at TMF, Pebble.  Source: Arguably ahead of its time with one of the best hardware and software all at an affordable pr...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Future of Medicine Health Sensors & Trackers digital health google healthcare design health technology digital technology Fitbit acquisitions Source Type: blogs

Related Links:

Recent studies have highlighted the multidimensional effect of atopic dermatitis (AD) and urticaria. Patient burden for these conditions is largely driven by the intense itching, sleep disturbance, comorbidities, and mental health illness associated with these diseases.1-3 Immunologic, microbial, and epithelial interactions have been reported to play an important role in AD.4,5 Novel therapies and management approaches are targeting the mechanisms underlying AD and urticaria.6,7 The current issue of the Annals contains 3 outstanding reviews that update readers on the pathophysiology and evolving treatments for AD and chronic urticaria.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Editorial Source Type: research
Conclusions: The knowledge about the cause, possible susceptibility, better treatment options, and attitude of the participants were similar to other low-income settings. The negative attitude was high and multidimensional. All stakeholders must work to increase awareness about the cause, symptoms, and treatment options for epilepsy and to decrease the negative attitude of the community. PMID: 31814856 [PubMed - in process]
Source: Behavioural Neurology - Category: Neurology Authors: Tags: Behav Neurol Source Type: research
AbstractIn paediatrics, clinical study data are limited, especially on herbal medicinal products. To address this gap, 2063 datasets from the paediatric population were evaluated in the PhytoVIS data base. By screening for paediatric data, information on indication, gender, treatment, co-medication and tolerability were evaluated. The majority of patients was treated because of common cold, fever, digestive complaints, skin diseases, sleep disturbances and anxiety. The perceived effect of the therapy was rated in 84% of the patients as very good or good without adverse events. The data shed light on a still neglected field...
Source: European Journal of Pediatrics - Category: Pediatrics Source Type: research
Publication date: Available online 9 December 2019Source: The Journal of Prosthetic DentistryAuthor(s): Mariana B. Câmara-Souza, Olívia M.C. Figueredo, Renata C.M. Rodrigues GarciaAbstractStatement of problemOcclusal devices are the gold standard for managing the signs and symptoms of sleep bruxism (SB). Nevertheless, their influence on the tongue, quality of life, and sleep quality is not clear.PurposeThe purpose of this prospective clinical study was to evaluate the effects of an occlusal device on maximum tongue force, oral health–related quality of life (OHRQoL), and subjective sleep quality in indiv...
Source: The Journal of Prosthetic Dentistry - Category: Dentistry Source Type: research
Publication date: Available online 9 December 2019Source: Neuroscience &Biobehavioral ReviewsAuthor(s): Joscha Böhnlein, Luisa Altegoer, Nina Kristin Muck, Kati Roesmann, Ronny Redlich, Udo Dannlowski, Elisabeth J. LeehrABSTRACTAlthough Exposure Therapy (ET) is the first-line treatment of Specific Phobia (SP), there is no clear consensus on which factors influence its success, and thus on how to conduct it most efficiently. This review summarizes the current state of research regarding this topic. N = 111 studies were in accordance with our eligibility criteria: participants had at least symptoms of ...
Source: Neuroscience and Biobehavioral Reviews - Category: Neuroscience Source Type: research
Publication date: Available online 9 December 2019Source: NeuronAuthor(s): Michelle C.D. Bridi, Fang-Jiao Zong, Xia Min, Nancy Luo, Trinh Tran, Jiaqian Qiu, Daniel Severin, Xue-Ting Zhang, Guanglin Wang, Zheng-Jiang Zhu, Kai-Wen He, Alfredo KirkwoodSummaryA balance between synaptic excitation and inhibition (E/I balance) maintained within a narrow window is widely regarded to be crucial for cortical processing. In line with this idea, the E/I balance is reportedly comparable across neighboring neurons, behavioral states, and developmental stages and altered in many neurological disorders. Motivated by these ideas, we ...
Source: Neuron - Category: Neuroscience Source Type: research
Condition:   Sleep Apnea Intervention:   Device: NightOwl Sponsor:   Ectosense NV Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Conditions:   Epilepsy;   Seizures Intervention:   Other: Modified Atkins Diet Sponsors:   University of Wisconsin, Madison;   Wisconsin Institute for Clinical Research Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Melatonin and standard therapy for IBS;   Other: Standard medical therapy and placebo Sponsor:   Sanjay Gandhi Postgraduate Institute of Medical Sciences Not yet recruiting
Source: - Category: Research Source Type: clinical trials
HOW TO get rid of visceral fat: Visceral fat is the most dangerous form of fat due to its location in the body. While it well understood that diet and exercise plays a key role in combating visceral fat, sleep also plays a key role - but what is the optimal amount?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
More News: Advertising | China Health | Information Technology | Orthopaedics | Sleep Disorders | Sleep Medicine | Study